Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year -- Second pivotal development ...
The presentation provides an overview of the Company’s operational and financial performance to date, growth strategy, and key priorities for the next phase of development. The ...
The Tbilisi Presentation Centre serves as the hub of this experience, showcasing how Eagle Hills’ developments are redefining ...
Geochemist Rens Verburg, senior vice president and technical fellow in geochemistry at the engineering and professional ...
Georgia’s beauty deserves developments that respect its landscapes, empower its people, and build prosperity that lasts. That ...
OpenAI's new browser is a surface for the company to distribute ChatGPT and develop new AI features rather than improving ...
LUND, SE / ACCESS Newswire / October 27, 2025 / BioInvent International AB ("BioInvent")(Nasdaq Stockholm:BINV)(STO:BINV) invites investors, analysts and the press to a presentation of the interim rep ...
Phase 1 data of first-in-class NBD1 stabilizers, SION-719 and SION-451, demonstrated they were generally well tolerated and exceeded desired pharmacokinetic targets ...
Presenting Author: Aftab Ala, MBBS, M.D., FRCP, Ph.D. The abstract is currently available on the conference website, and the materials for the oral presentation will be available at www.monopartx.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback